Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients
-
Published:2023-02-15
Issue:11
Volume:65
Page:1796-1808
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Shang Fanjing, Wang Yafei, Shi Zixu, Deng Zhidong, Ma JianwenORCID
Abstract
AbstractGastric cancer (GC) has been a common tumor type with high mortality. Distal metastasis is one of the main causes of death in GC patients, which is also related to poor prognosis. The mRNA profiles and clinical information of GC patients were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. Univariate Cox and LASSO Cox analyses were used to screen the optimal metastasis-related genes (MRGs) to establish a prognostic Risk Score model for GC patients. The nomogram was used to visualize the Risk Score and predict the 1-, 3-, 5-year survival rate. The immune cell infiltration was analyzed by CIBERSORT and the ratio of immune–stromal component was calculated by the ESTIMATE algorithm. A total of 142 differentially expressed genes were identified between metastatic and non-metastatic GC samples. The optimal 8 genes, comprising GAMT (guanidinoacetate N-methyltransferase), ABCB5 (ATP-binding cassette subfamily B member 5), ITIH3 (inter-alpha-trypsin inhibitor heavy chain 3), GDF3 (growth differentiation factor 3), VSTM2L (V-set and transmembrane domain-containing 2 like), CIDEA (cell death inducing DFFA like effector a), NPTX1 (neuronal pentraxin-1), and UMOD (uromodulin), were further screened to establish a prognostic Risk Score, which proved to be an independent prognostic factor. Patients in high-risk group had a poor prognosis. There were significant differences in the proportion of 11 tumor-infiltrating immune cells between high-risk and low-risk subgroups. In addition, the StromalScore, ImmuneScore, and ESTIMATEScore in high-risk group were higher than those in low-risk group, indicating that the tumor microenvironment of the high-risk group was more complex. A Risk Score model based on eight metastasis-related genes could clearly distinguish the prognosis of GC patients. The poor prognosis of patients with high-Risk Score might be associated with the complex tumor microenvironments.
Funder
Central University Fund
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference52 articles.
1. Gullo, I., Grillo, F., Mastracci, L., Vanoli, A., Carneiro, F., et al. (2020). Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica, 112, 166–185. 2. Han, S., Park, S., An, J., Yang, J. Y., Chung, J. W., et al. (2020). HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer. Science and Reports, 10, 5270. 3. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249. 4. Eusebi, L. H., Telese, A., Marasco, G., Bazzoli, F., & Zagari, R. M. (2020). Gastric cancer prevention strategies: A global perspective. Journal of Gastroenterology and Hepatology, 35, 1495–1502. 5. Chen, X., Dai, X., Zou, P., Chen, W., Rajamanickam, V., et al. (2017). Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer. British Journal of Pharmacology, 174, 1131–1146.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|